Carlo Cenciarelli

Years Active: 2019-2023
Publications (10 Years): 6

National Research Council (CNR)

International Education Evaluations Inc. (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Research Council (CNR) Dec 16 2009

Italy

Researcher :: Institute of Translational Pharmacology

ATENA Foundation Jan 01 2004 - Aug 31 2009

Italy

Researcher :: Insitute of Cell Biology and Neurobiology-IBCN-CNR

National Research Council (CNR) Sep 01 2000 - Dec 31 2002

Italy

Researcher :: Insitute of Cell Biology

NYU-MC Jun 15 1997 - Dec 31 1999

United States

Research Assistant Scientist :: Pathology and Pediatrics

Education History

International Education Evaluations Inc. - Apr 10 2003

United States

PHD

Università degli Studi di Roma La Sapienza Jan 07 1991 - Mar 10 1993

Italy

PHD

Publications

Hany El Sayed Marei, Carlo Cenciarelli
Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies. Biomedicines 11 (2) (2023)
Hany El Sayed Marei, Carlo Cenciarelli
Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies. Biomedicines 11 (2) (2023)
Hany El Sayed Marei, Carlo Cenciarelli
Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies. Biomedicines 11 (2) (2023)
Hany El Sayed Marei, Asmaa Althani, Nahla Afifi, Anwarul Hasan, Thomas Caceci, Giacomo Pozzoli, Carlo Cenciarelli
Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme. Cancer medicine 10 (15) (2021)
Giacomo Pozzoli, Giovanna Petrucci, Pierluigi Navarra, Hany E Marei, Carlo Cenciarelli
Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation. Journal of cellular and molecular medicine 23 (10) (2019)
Giacomo Pozzoli, Hany E Marei, Asma Althani, Alma Boninsegna, Patrizia Casalbore, Lionel N J L Marlier, Giulia Lanzilli, Manuela Zonfrillo, Giovanna Petrucci, Bianca Rocca, Pierluigi Navarra, Alessandro Sgambato, Carlo Cenciarelli
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation. Journal of cellular physiology (2019)

Carlo Cenciarelli.css-eqlu8i{font-size:small;padding-left:4px;}